Your browser doesn't support javascript.
loading
A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026).
Cranston, Ross D; Brown, Elizabeth; Bauermeister, José; Dunne, Eileen F; Hoesley, Craig; Ho, Ken; Johnson, Sherri; Lucas, Jonathan; Dominguez-Islas, Clara; Gundacker, Holly; Peda, Melissa; Jacobson, Cindy E; Kramzer, Lindsay; Singh, Devika; Dezzutti, Charlene S; Kunjara Na Ayudhya, Ratiya Pamela; Brand, Rhonda M; Wang, Lin; Marzinke, Mark A; Piper, Jeanna; Devlin, Bríd; Nuttall, Jeremy; McGowan, Ian; Hendrix, Craig W.
  • Cranston RD; Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Brown E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Bauermeister J; Department of Family and Community Health, University of Pennsylvania, Pennsylvania, Philadelphia, USA.
  • Dunne EF; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Hoesley C; Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.
  • Ho K; Department of Medical Education, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Johnson S; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Lucas J; FHI 360, Durham, North Carolina, USA.
  • Dominguez-Islas C; FHI 360, Durham, North Carolina, USA.
  • Gundacker H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Peda M; Statistical Center for HIV/AIDS Research & Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Jacobson CE; Statistical Center for HIV/AIDS Research & Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Kramzer L; Microbicide Trials Network, Pittsburgh, Pennsylvania, USA.
  • Singh D; Microbicide Trials Network, Pittsburgh, Pennsylvania, USA.
  • Dezzutti CS; Microbicide Trials Network, Pittsburgh, Pennsylvania, USA.
  • Kunjara Na Ayudhya RP; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Brand RM; Microbicide Trials Network, Pittsburgh, Pennsylvania, USA.
  • Wang L; Microbicide Trials Network, Pittsburgh, Pennsylvania, USA.
  • Marzinke MA; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Piper J; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Devlin B; Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Nuttall J; Division of AIDS/NIAID/NIH, Bethesda, Maryland, USA.
  • McGowan I; International Partnership for Microbicides, Silver Spring, Maryland, USA.
  • Hendrix CW; International Partnership for Microbicides, Silver Spring, Maryland, USA.
AIDS Res Hum Retroviruses ; 38(4): 257-268, 2022 04.
Article en En | MEDLINE | ID: mdl-34498980
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male País como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male País como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article